Bill > HB1520

This bill expands the scope of practice for pharmacists in Washington state, recognizing them as highly educated healthcare professionals capable of providing more direct patient care. Beginning December 1, 2026, pharmacists will be authorized to prescribe a range of medications and treatments, including immunizations, opioid antagonists, epinephrine autoinjectors, antihistamines, tobacco cessation products, HIV prevention medications, tuberculin products, hormonal contraception, travel-related medications, and other drugs for minor, self-limiting conditions that do not require a new diagnosis. The bill aims to improve healthcare access, particularly in rural and underserved communities, by allowing pharmacists to practice at the full extent of their training and expertise. Key provisions include the ability to diagnose certain conditions, prescribe specific drugs and devices, and participate in team-based medical practices with shared medical records. The expanded prescribing authority will be in effect until January 1, 2030, at which point the provisions will expire, and the pharmacy quality assurance commission is authorized to develop rules for implementing these changes. The legislative intent is to leverage pharmacists' expertise to enhance patient outcomes for both behavioral and physical health.

Health and Social Services

https://app.leg.wa.gov/billsummary?BillNumber=1520&Year=2025&Initiative=false